These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

713 related articles for article (PubMed ID: 27048897)

  • 1. Probiotics and prebiotics in ulcerative colitis.
    Derikx LA; Dieleman LA; Hoentjen F
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):55-71. PubMed ID: 27048897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prebiotics and Probiotics in Inflammatory Bowel Disease: Where are we now and where are we going?
    Naseer M; Poola S; Ali S; Samiullah S; Tahan V
    Curr Clin Pharmacol; 2020; 15(3):216-233. PubMed ID: 32164516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics and prebiotics in Crohn's disease therapies.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):81-8. PubMed ID: 27048899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current place of probiotics and prebiotics in the treatment of pouchitis.
    Lichtenstein L; Avni-Biron I; Ben-Bassat O
    Best Pract Res Clin Gastroenterol; 2016 Feb; 30(1):73-80. PubMed ID: 27048898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics in the Management of Ulcerative Colitis.
    Chibbar R; Dieleman LA
    J Clin Gastroenterol; 2015; 49 Suppl 1():S50-5. PubMed ID: 26447965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease.
    Orel R; Kamhi Trop T
    World J Gastroenterol; 2014 Sep; 20(33):11505-24. PubMed ID: 25206258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics are a good choice in remission of inflammatory bowel diseases: A meta analysis and systematic review.
    Ganji-Arjenaki M; Rafieian-Kopaei M
    J Cell Physiol; 2018 Mar; 233(3):2091-2103. PubMed ID: 28294322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis.
    Dang X; Xu M; Liu D; Zhou D; Yang W
    PLoS One; 2020; 15(3):e0228846. PubMed ID: 32182248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Efficacy of Probiotics, Prebiotic Inulin-Type Fructans, and Synbiotics in Human Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Astó E; Méndez I; Audivert S; Farran-Codina A; Espadaler J
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30704039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: An update.
    Scaldaferri F; Gerardi V; Mangiola F; Lopetuso LR; Pizzoferrato M; Petito V; Papa A; Stojanovic J; Poscia A; Cammarota G; Gasbarrini A
    World J Gastroenterol; 2016 Jun; 22(24):5505-11. PubMed ID: 27350728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: a double-blind randomized placebo controlled clinical trial.
    Petersen AM; Mirsepasi H; Halkjær SI; Mortensen EM; Nordgaard-Lassen I; Krogfelt KA
    J Crohns Colitis; 2014 Nov; 8(11):1498-505. PubMed ID: 24972748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics, probiotics and prebiotics in IBD.
    Bernstein CN
    Nestle Nutr Inst Workshop Ser; 2014; 79():83-100. PubMed ID: 25227297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E; Pascarella F; Giannetti E; Quaglietta L; Baldassano RN; Staiano A
    Am J Gastroenterol; 2009 Feb; 104(2):437-43. PubMed ID: 19174792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
    Kruis W; Fric P; Pokrotnieks J; Lukás M; Fixa B; Kascák M; Kamm MA; Weismueller J; Beglinger C; Stolte M; Wolff C; Schulze J
    Gut; 2004 Nov; 53(11):1617-23. PubMed ID: 15479682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maintaining remission of ulcerative colitis with the probiotic Escherichia Coli Nissle 1917 is as effective as with standard mesalazine].
    Adam B; Liebregts T; Holtmann G
    Z Gastroenterol; 2006 Mar; 44(3):267-9. PubMed ID: 16514573
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum.
    Guo J; Li L; Cai Y; Kang Y
    Cell Commun Signal; 2024 May; 22(1):268. PubMed ID: 38745207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Probiotics in chronic inflammatory bowel disease].
    Böhm S; Kruis W
    MMW Fortschr Med; 2006 Aug; 148(35-36):30-4. PubMed ID: 16995360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probiotics in Inflammatory Bowel Disease.
    Abraham BP; Quigley EMM
    Gastroenterol Clin North Am; 2017 Dec; 46(4):769-782. PubMed ID: 29173520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Synbiotics for Ulcerative Colitis Treatment.
    Roselli M; Finamore A
    Curr Clin Pharmacol; 2020; 15(3):174-182. PubMed ID: 31878863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.